Abstract
The antioxidant capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles was evaluated. The values of antioxidant capacities of compounds 2d and 2e were found to be, respectively, 2,700 ± 150 and 3,135 ± 230 TE by the ORAC method, corresponding to a significant antioxidant capacity.
Keywords: Antioxidant, Antioxidant synthetic, Green chemistry, Thiazole, Trolox, ORAC, Antioxidant Capacity, Blenoxane, Bleomycine, Tiazofurin, Antineoplastic agents, Thiazolyl compounds, Antioxidants, ORAC Methodology, Putative antioxidants, Antimicrobial agents, Anticancer agents, Reverse transcriptase inhibitors, α-blocking agents, High throughput assay, Antioxidant agents, Hypotenstive activity
Letters in Drug Design & Discovery
Title: Antioxidant Capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles
Volume: 7 Issue: 9
Author(s): F. A.N. Silva, L. Pizzuti, F. H. Quina, S. P. Souza, P. F. Rosales, G. M. Siqueira, C. M.P. Pereira, S. B.M. Barros and D. P. Rivelli
Affiliation:
Keywords: Antioxidant, Antioxidant synthetic, Green chemistry, Thiazole, Trolox, ORAC, Antioxidant Capacity, Blenoxane, Bleomycine, Tiazofurin, Antineoplastic agents, Thiazolyl compounds, Antioxidants, ORAC Methodology, Putative antioxidants, Antimicrobial agents, Anticancer agents, Reverse transcriptase inhibitors, α-blocking agents, High throughput assay, Antioxidant agents, Hypotenstive activity
Abstract: The antioxidant capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles was evaluated. The values of antioxidant capacities of compounds 2d and 2e were found to be, respectively, 2,700 ± 150 and 3,135 ± 230 TE by the ORAC method, corresponding to a significant antioxidant capacity.
Export Options
About this article
Cite this article as:
A.N. Silva F., Pizzuti L., H. Quina F., P. Souza S., F. Rosales P., M. Siqueira G., M.P. Pereira C., B.M. Barros S. and P. Rivelli D., Antioxidant Capacity of 2-(3,5-diaryl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazoles, Letters in Drug Design & Discovery 2010; 7(9) . https://dx.doi.org/10.2174/157018010792929513
DOI https://dx.doi.org/10.2174/157018010792929513 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of Procalcitonin in Sepsis and Septic Shock
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study
Current Angiogenesis (Discontinued) Isolation and Boactivities of Furfuran Type Lignan Compounds from Edible Plants
Recent Patents on Food, Nutrition & Agriculture Editorial
Current Pediatric Reviews IL-1 Cytokines in Cardiovascular Disease: Diagnostic, Prognostic and Therapeutic Implications
Cardiovascular & Hematological Agents in Medicinal Chemistry Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) COVID-19 Pandemic and the Impact on the Cardiovascular Disease Patient Care
Current Cardiology Reviews Technological Options for the Production of Health-Promoting Proteins and Peptides Derived from Milk and Colostrum
Current Pharmaceutical Design Imidazoline Receptors, Novel Agents and Therapeutic Potential
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacological Treatments of Opiate Dependence
Current Pharmaceutical Design Recent Applications of Nanomaterials Based on Electrochemical Drug Analysis
Current Analytical Chemistry Multiple Functions of Mammalian Germinal Center Kinases
Current Chemical Biology Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents IL-2, IL-7 and IL-15 as Immuno-Modulators During SIV/HIV Vaccination and Treatment
Current HIV Research Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets Targeting NO Signaling for the Treatment of Osteoporosis
Current Medicinal Chemistry Obesity and Cardiovascular Physiology: Impact of some Pharmacological Agents
Current Vascular Pharmacology Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma
Current Pharmaceutical Biotechnology Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia
Current Pharmaceutical Design